A 45-year-old Virginia woman’s death due to a rare blood clot days after receiving the Johnson & Johnson COVID-19 vaccine is connected to the Centers for Disease Control & Prevention’s call for a pause on administering the one-dose vaccine, state health officials confirmed Tuesday.
“The U.S. Centers for Disease Control & Prevention (CDC) confirmed to the Virginia Department of Health (VDH) that it is examining the March death of a Virginia woman as part of its investigation into possible adverse side effects from the Johnson & Johnson COVID-19 vaccine,” state vaccination coordinator Dr. Danny Avula said in a statement released Tuesday night.
The Virginia woman died on March 18 from stroke-like symptoms in a Virginia hospital, according to a CDC report in the public Vaccine Adverse Event Reporting System.
